Detalhe da pesquisa
1.
The cost and cost-effectiveness of novel tuberculosis vaccines in low- and middle-income countries: A modeling study.
PLoS Med
; 20(1): e1004155, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36693081
2.
Schistosomiasis - Assessing Progress toward the 2020 and 2025 Global Goals.
N Engl J Med
; 381(26): 2519-2528, 2019 12 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-31881138
3.
Schistosomiasis and the Global Goals. Reply.
N Engl J Med
; 382(16): 1576, 2020 04 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-32294367
4.
Direct estimates of absolute ventilation and estimated Mycobacterium tuberculosis transmission risk in clinics in South Africa.
PLOS Glob Public Health
; 2(11): e0000603, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36962521
5.
Modelling the effect of infection prevention and control measures on rate of Mycobacterium tuberculosis transmission to clinic attendees in primary health clinics in South Africa.
BMJ Glob Health
; 6(10)2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34697087
6.
Estimating ventilation rates in rooms with varying occupancy levels: Relevance for reducing transmission risk of airborne pathogens.
PLoS One
; 16(6): e0253096, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34166388
7.
Associations between infection intensity categories and morbidity prevalence in school-age children are much stronger for Schistosoma haematobium than for S. mansoni.
PLoS Negl Trop Dis
; 15(5): e0009444, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34033646
8.
Evaluating the variation in the projected benefit of community-wide mass treatment for schistosomiasis: Implications for future economic evaluations.
Parasit Vectors
; 10(1): 213, 2017 Apr 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-28454578